logo
tagline
 
 
Mapi Values success at ISPOR European Congress

Mapi Values received an ISPOR Best Research Presentation Award for the poster: How do postmenopausal women describe breast pain and breakthrough bleeding associated with hormonal treatments for menopausal symptoms: qualitative interviews with postmenopausal women in the United States, China, Mexico and Italy Abraham L, Arbuckle R, Dennerstein L, Humphrey L, Maguire L, Mirkin S, Simon JA, Symonds T, Walmsley S
Louise Humphrey, from Mapi Values said “Winning the best poster award at ISPOR was a real buzz. The people that come together at ISPOR are at the forefront of health outcomes research, so it’s great to get recognition from such an informed peer group.” Mapi Values also won finalist rosettes for two further posters. For a copy of any of the posters, please contact Vicky Hope
 
NEXT NEWS STORY|VIEW ARCHIVED NEWS|CLOSE THIS WINDOW
 
 
 
 
Listening to Patients
Read the article from Benoit Arnould, featured on pharmaphorum.com.
 
NEXT NEWS STORY|VIEW ARCHIVED NEWS|CLOSE THIS WINDOW
 
 
 
 
December is Cancer-Related Fatigue Awareness Month
More than 70% of cancer patients receiving treatment suffer from fatigue, for some, lasting months or years after treatment. Cancer-related fatigue is pervasive into a person’s life and can negatively impact compliance with the treatment. Yet, cancer-related fatigue remains an under-reported and untreated diagnosis, in part because of differences in measurement and definition. Source: Cancer Institute of New Jersey
The Patient Reported Outcomes of Fatigue in Cancer (PROOF-C) consortium was established in 2007 to help clarify how cancer fatigue should be conceptualized for measurement in clinical trials so clinical research and care for cancer patients experiencing cancer fatigue could advance. The PROOF-C consortium is a collaborative research project.
For more information on PROOF-C click here

 
NEXT NEWS STORY|VIEW ARCHIVED NEWS|CLOSE THIS WINDOW
 
Mapi Values Skillsets Realigned in Support of Client Needs and Growth

Cheshire, UK and Lyon, France – December 14th 2011

The Mapi and Adelphi Groups are pleased to announce a realignment of their Health Outcomes joint venture, Mapi Values. Following 20 years of successful partnership, a change in structure and focus will provide clients with more service clarity, whilst giving both groups improved support and new strategic opportunities.

“Over the last 20 years the Mapi Values alliance has created a best-in-class business in the expanding fields of Health Outcomes and Economics generating meaningful evidence and informed decisions” said Stuart Cooper, CEO of the Adelphi Group. “Indeed, we have been proud to drive the development of a global service offering, frequently working directly with regulatory bodies which have become increasingly important within our industry”, agreed Bernard Jambon, Chairman of the Mapi Group.

The move comes as the services supporting health outcomes are rapidly evolving. The two group heads commented that “Now, more than ever, a focus on core competencies across synergistic disciplines has become the key to delivering optimal value to our customers” and reiterated that “appropriate skills are best positioned to provide the most comprehensive and synergistic approach to service delivery possible”.

It has therefore been decided to align the US and UK based Mapi Values Global PRO, Psychometrics, Statistics, and Value Insight teams within the Adelphi Group, alongside its wider market access, pricing, real-world and communication capabilities. This company will operate under the name Adelphi Values. The Netherlands, US and UK based Clinical & Economic Evidence teams, and the French based PRO / Statistics teams will be aligned within the Mapi Group, operating under the name of Mapi Consultancy. This alignment complements the Mapi Group linguistic validation, late phase studies and market access capabilities.

Clients will continue to receive the same level of quality and value they have come to expect. Each company remains committed to business continuity, and will continue to partner on client engagements as required, in order to deliver industry-leading solutions and services.